CAS 32694-37-4

Formule : C19H28O3

InChI : InChI=1S/C19H28O3/c1-18-8-7-12(20)9-11(18)3-4-13-14-5-6-16(22)19(14,2)10-15(21)17(13)18/h11,13-14,16-17,22H,3-10H2,1-2H3/t11-,13-,14-,16-,17+,18-,19-/m0/s1

Code InChI : RSQKILYTRHKUIJ-HZGXJFKTSA-N

SMILES : C[C@]12CCC(=O)C[C@@H]1CC[C@@H]3[C@@H]2C(=O)C[C@]4([C@H]3CC[C@@H]4O)C

11-Ketodihydrotestosterone

CAS : 32694-37-4

11-Ketodihydrotestosterone is a metabolite of 11β-Hydroxyandrostenedione. It is an active androgen and is also a potent androgen receptor (AR) agonist (Ki: 20.4 nM, EC50: 1.35 nM for human AR).

Formule : C₁₉H₂₈O₃

Couleur et forme : Solid

Masse moléculaire : 304.42

Ref: TM-T10041

11-Ketodihydrotestosterone

Produit contrôlé

CAS : 32694-37-4

Formule : C₁₉H₂₈O₃

Couleur et forme : Neat

Masse moléculaire : 304.424

Ref: TR-K125450

11-Ketodihydrotestosterone-[16.16.17-d3]

CAS : 32694-37-4

Formule : C₁₉H₂₈O₃

Masse moléculaire : 304.4

Ref: BE-MD-2837

11-Ketodihydrotestosterone

CAS : 32694-37-4

Formule : C₁₉H₂₈O₃

Masse moléculaire : 304.4

Ref: BE-MU-2837

11-Ketodihydrotestosterone

Produit contrôlé

CAS : 32694-37-4

11-Ketodihydrotestosterone is a steroid hormone that is synthesized from the male sex hormone testosterone. 11-Ketodihydrotestosterone has been shown to have anti-proliferative effects in vitro and in vivo, and may be a potential therapeutic agent for cancer treatment. It also has relevance as a drug to treat polycystic ovarian syndrome and clinical symptoms of prostate cancer such as bone pain. 11-Ketodihydrotestosterone is expressed by humans, but there are no reports of its catalysis or physiological function.

Formule : C₁₉H₂₈O₃

Degré de pureté : Min. 95%

Masse moléculaire : 304.4 g/mol

Ref: 3D-HBA69437